Kata Nóra Enyedi Selected Research

Daunorubicin (Cerubidine)

3/2024	Characterisation of the cell and molecular biological effect of peptide-based daunorubicin conjugates developed for targeting pancreatic adenocarcinoma (PANC-1) cell line.
12/2023	Three-dimensional, PEG-based hydrogels induce spheroid formation and enhance viability of A2058 melanoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kata Nóra Enyedi Research Topics

Disease

9	Neoplasms (Cancer) 08/2023 - 02/2015
3	Melanoma (Melanoma, Malignant) 12/2023 - 02/2015
3	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2015
3	Colonic Neoplasms (Colon Cancer) 08/2019 - 01/2017
2	Fibrosarcoma 01/2018 - 01/2017
1	Adenocarcinoma 03/2024
1	Mesoblastic Nephroma (Congenital Mesoblastic Nephroma) 03/2015

Drug/Important Bio-Agent (IBA)

8	Peptides (Polypeptides)IBA 03/2024 - 02/2015
5	CD13 Antigens (Alanine Aminopeptidase)IBA 08/2023 - 03/2015
3	asparagine-glycine-arginineIBA 08/2023 - 01/2017
3	RadiopharmaceuticalsIBA 08/2023 - 11/2020
3	IntegrinsIBA 01/2018 - 03/2015
2	Daunorubicin (Cerubidine)FDA LinkGeneric 03/2024 - 12/2023
1	Phenylalanine (L-Phenylalanine)FDA Link 03/2024
1	HydrogelsIBA 12/2023
1	actinoninIBA 01/2021
1	ubenimexIBA 01/2021
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 11/2020
1	polypeptide CIBA 11/2020
1	68Ga-NOTA-c(NGR)IBA 11/2020
1	Protein Isoforms (Isoforms)IBA 01/2017
1	NGR peptideIBA 01/2017
1	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 03/2015

Therapy/Procedure

6	Therapeutics 08/2023 - 03/2015
1	Subcutaneous Injections 11/2020
1	Intravenous Injections 11/2020
1	Transplantation 03/2015